MicroRNAs in fibrosis: opportunities and challenges

por O’Reilly, Steven
Publicado 2016

Circulating Gremlin-1 is elevated in systemic sclerosis patients

por O’Reilly, Steven
Publicado 2021

Keeping time on liver fibrosis

por O’Reilly, Steven
Publicado 2021

Epigenetic Modulation as a Therapeutic Prospect for Treatment of Autoimmune Rheumatic Diseases

por Ciechomska, Marzena, O'Reilly, Steven
Publicado 2016

A MicroRNA that Regulates TLR-Mediated Fibrosis

por Duffy, Laura, O’Reilly, Steven
Publicado 2016

Inflammasome lights up in systemic sclerosis

por Henderson, John, O’Reilly, Steven
Publicado 2017

Current and Potential New Targets in Systemic Sclerosis Therapy: a New Hope

por Hinchcliff, Monique, O’Reilly, Steven
Publicado 2020

Toll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developments

por Duffy, Laura, O’Reilly, Steven C
Publicado 2016

Interleukin-6: a new therapeutic target in systemic sclerosis?

por O'Reilly, Steven, Cant, Rachel, Ciechomska, Marzena, van Laar, Jacob M
Publicado 2013

Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis

por Henderson, John, Duffy, Laura, Stratton, Richard, Ford, Dianne, O’Reilly, Steven
Publicado 2020

Differentiation Potential of CD14(+) Monocytes into Myofibroblasts in Patients with Systemic Sclerosis

por Binai, Nadine, O'Reilly, Steven, Griffiths, Bridget, van Laar, Jacob M., Hügle, Thomas
Publicado 2012

IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics

por O’Reilly, Steven, Ciechomska, Marzena, Fullard, Nicola, Przyborski, Stefan, van Laar, Jacob M.
Publicado 2016

Corrigendum: IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics

por O’Reilly, Steven, Ciechomska, Marzena, Fullard, Nicola, Przyborski, Stefan, van Laar, Jacob M.
Publicado 2016

MiR-29a Reduces TIMP-1 Production by Dermal Fibroblasts via Targeting TGF-β Activated Kinase 1 Binding Protein 1, Implications for Systemic Sclerosis

por Ciechomska, Marzena, O’Reilly, Steven, Suwara, Monika, Bogunia-Kubik, Katarzyna, van Laar, Jacob M.
Publicado 2014

The Cell-Permeable Derivative of the Immunoregulatory Metabolite Itaconate, 4-Octyl Itaconate, Is Anti-Fibrotic in Systemic Sclerosis

por Henderson, John, Dayalan Naidu, Sharadha, Dinkova-Kostova, Albena T., Przyborski, Stefan, Stratton, Richard, O′Reilly, Steven
Publicado 2021

Epigenetics as a versatile regulator of fibrosis

por Liu, Yangdan, Wen, Dongsheng, Ho, Chiakang, Yu, Li, Zheng, Danning, O’Reilly, Steven, Gao, Ya, Li, Qingfeng, Zhang, Yifan
Publicado 2023

Bone Morphogenetic Protein Antagonist Gremlin-1 Increases Myofibroblast Transition in Dermal Fibroblasts: Implications for Systemic Sclerosis

por Duffy, Laura, Henderson, John, Brown, Max, Pryzborski, Stefan, Fullard, Nicola, Summa, Lena, Distler, Jorg H. W., Stratton, Richard, O’Reilly, Steven
Publicado 2021

Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors

por Ciechomska, Marzena, Huigens, Christiaan A, Hügle, Thomas, Stanly, Tess, Gessner, Andreas, Griffiths, Bridget, Radstake, Timothy R D J, Hambleton, Sophie, O'Reilly, Steven, van Laar, Jacob M
Publicado 2013

Differential MicroRNA Expression Levels in Cutaneous Acute Graft-Versus-Host Disease

por Atarod, Sadaf, Norden, Jean, Bibby, Louis A., Janin, Anne, Ratajczak, Philippe, Lendrem, Clare, Pearce, Kim F., Wang, Xiao-Nong, O’Reilly, Steven, Van Laar, Jacob M., Collin, Matthew, Dickinson, Anne M., Crossland, Rachel E.
Publicado 2018

Bioengineering the microanatomy of human skin

por Roger, Mathilde, Fullard, Nicola, Costello, Lydia, Bradbury, Steven, Markiewicz, Ewa, O'Reilly, Steven, Darling, Nicole, Ritchie, Pamela, Määttä, Arto, Karakesisoglou, Iakowos, Nelson, Glyn, von Zglinicki, Thomas, Dicolandrea, Teresa, Isfort, Robert, Bascom, Charles, Przyborski, Stefan
Publicado 2019